avapro has been researched along with Heart Failure, Systolic in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Heart Failure, Systolic: Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Impaired insulin sensitivity is common in patients with chronic systolic heart failure (CHF) and contributes to symptomatic status and impaired prognosis." | 2.77 | Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study. ( Anker, SD; Doehner, W; Kennecke, C; Lainscak, M; Rauchhaus, M; Sandek, A; Todorovic, J; Tschöpe, C; van Linthout, S; von Haehling, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doehner, W | 1 |
| Todorovic, J | 1 |
| Kennecke, C | 1 |
| Rauchhaus, M | 1 |
| Sandek, A | 1 |
| Lainscak, M | 1 |
| van Linthout, S | 1 |
| Tschöpe, C | 1 |
| von Haehling, S | 1 |
| Anker, SD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of the Angiotensin II Receptor Antagonist Irbesartan on Insulin Sensitivity and Metabolic Profile in Patients With Chronic Heart Failure[NCT00347087] | Phase 4 | 36 participants (Actual) | Interventional | 2004-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for avapro and Heart Failure, Systolic
| Article | Year |
|---|---|
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study.
Topics: Aged; Angiotensin Receptor Antagonists; Biphenyl Compounds; Double-Blind Method; Female; Heart Failu | 2012 |